NCT02967796 is a clinical trial of Proteochoc in Postpartum Perineal Pain, sponsored by PiLeJe.

Who is sponsoring NCT02967796?

NCT02967796 is sponsored by PiLeJe.

What drugs are being tested in NCT02967796?

Interventions in NCT02967796: Proteochoc.

What condition does NCT02967796 study?

NCT02967796 studies Postpartum Perineal Pain.

Is NCT02967796 still recruiting?

NCT02967796 is currently completed. Last updated 17 July 2018.

Last reviewed 2018-07-17 · How we verify

NCT02967796

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Strategy of Micronutrient Management in Parturient and Layered Women With a Dietary Supplement Rich in Porphyra HSP®

Completed Last updated 17 July 2018

What this trial tests

trial testing Proteochoc in Postpartum Perineal Pain in 60 participants. Completed in 25 April 2017.

Timeline

4 September 2015

Primary endpoint
25 April 2017

25 April 2017

Quick facts

Lead sponsor	PiLeJe
Status	Completed
Study type	OBSERVATIONAL
Enrollment	60
Start date	4 September 2015
Primary completion	25 April 2017
Estimated completion	25 April 2017
Sites	1 location across France

Drugs / interventions tested

Proteochoc

Conditions studied

Postpartum Perineal Pain — all drugs for Postpartum Perineal Pain →

Sponsor

PiLeJe — full company profile →

Who can join

18 and older, female only, with Postpartum Perineal Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate in primiparous patients the benefit of supplementation with Proteochoc® to reduce perineal pain in the postpartum especially, in sitting posture. The patient is followed from the delivery to 6 to 8 weeks after.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other PiLeJe trials

Trials by the same sponsor.

NCT04812418 — Evaluation of a Combination of Plants in Anxiety-related Sleep Disorders: Randomized Trial Versus Placebo · NA · completed
NCT04728269 — Exploratory Study on Lactibiane Topic AD on Skin Flora and Barrier Reinforcement in Mild to Moderate Atopic Dermatitis · NA · completed
NCT04574141 — Kinetic of Melatonin Subsequent to the Consumption of Melatonin-rich Food Supplements · NA · completed
NCT04628819 — Effect and Tolerability of Lactobacillus Rhamnosus GG LA801 for the Preventive Nutritional Care of Nosocomial Diarrhea i · NA · terminated
NCT04324658 — Effect and Tolerance of a Probiotic-based Medical Device Administered to Patients With Irritable Bowel Syndrome · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02967796 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by PiLeJe
Last refreshed: 17 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02967796.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing